Table of Contents

• 1. Product Specifications & Comparative Analysis
• 2. Key Applications & Industrial Use Cases
• 3. Implementation Scenarios
• 4. Client Success Stories
• 5. Contact for Technical Consultation

1. Product Specifications & Comparative Analysis

2. Key Applications & Industrial Use Cases

Pharmaceutical Intermediate

Critical component in kinase inhibitor development for:

• EGFR (Epidermal Growth Factor Receptor) inhibitors
• VEGFR (Vascular Endothelial Growth Factor Receptor) blockers
• PARP (Poly ADP-Ribose Polymerase) inhibitors

Agrochemical Research

Used in novel herbicide formulations demonstrating:

• Enhanced cellular uptake efficiency
• Improved thermal stability (up to 300°C)
• Reduced environmental persistence

3. Implementation Scenarios

Scenario 1: Oncology Drug Development

Used in Phase II clinical trial material synthesis for:

• Dose-response optimization (IC50: 12nM)
• Metabolic stability enhancement
• Selectivity ratio improvement (200:1 vs normal cells)

4. Client Success Stories

Case 1: ABC Pharmaceuticals (Shanghai)

Challenge: Needed high-purity intermediate for PD-L1 inhibitor development
Solution: Custom synthesis at 99.3% purity
Result: Accelerated IND submission by 6 months

Case 2: XYZ Biotech (Boston)

Challenge: Required stable fluorinated quinazoline derivative
Solution: Optimized nitro-fluoro substitution pattern
Result: Achieved 92% yield in GMP production

5. Contact for Technical Consultation

Request custom synthesis protocols or material safety data sheets:

info@vivalr.com
(86) 15866781826

Our technical team provides:

• 24-hour response time guarantee
• Regulatory support (REACH, FDA DMF)
• Custom analytical method development